title: The role of DNA repair capacity in melanoma skin cancer risk in a population chronically exposed to high levels of sunlight.
abstract: Puerto Rican residents are exposed to some of the highest levels of environmental ultraviolet radiation in the world; paradoxically, the melanoma incidence in Puerto Rico is lower than that of the US mainland. The overall objective of this case-control pilot study was to test the hypotheses that (1) persons with melanoma have a significantly lower DNA repair capacity (DRC) in relation to controls matched by age, (2) decline in DRC is associated with vertical depth of melanoma invasion, and (3) DRC is associated with anatomical tumor location. Controls (n  =  124) were examined by dermatologists; cases (n  =  62) were histopathologically confirmed. The mean DRC ± 1 SE of controls was 6.46% ± 0.3. Melanoma patients (n  =  62) had a mean decrease in DRC of 3% (6.25% ± 0.5), which was not statistically different from controls (P  =  0.697). No significant differences in DRC were evident in participants with either in situ or malignant melanoma tumors; neither were such differences evident when evaluating anatomical location of tumors (ie, non-sun-exposed versus sun-exposed). DRC generally declined in participants with increased depth of melanoma tumor penetration when compared with controls and those with small in situ tumors. These findings should be examined in a larger-scale population study that includes participants with more advanced metastatic melanoma.
authors: Jaime L
authors: JL
authors: Matta
authors: Giovanna
authors: G
authors: Rodriguez
authors: Jaime
authors: J
authors: Villa
authors: Abigail
authors: A
authors: Ruiz
references: J Natl Cancer Inst. 2002 Jul 17;94(14):1091-9
references: 12122100
references: Hum Biol. 2001 Aug;73(4):491-511
references: 11512677
references: J Natl Cancer Inst. 2002 Jun 19;94(12):872-3
references: 12072536
references: Cancer Res. 2002 Jul 15;62(14):3992-6
references: 12124332
references: Med J Aust. 1956 Jun 30;43(26):1082-7
references: 13347440
references: J Am Acad Dermatol. 2003 Sep;49(3):433-9
references: 12963906
references: Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):577-8
references: 8827363
references: Am J Phys Anthropol. 2005 Sep;128(1):131-55
references: 15693025
references: Annu Rev Genet. 1975;9:19-38
references: 1108765
references: Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2526-32
references: 17164380
references: Carcinogenesis. 1992 Mar;13(3):457-62
references: 1547537
references: J Natl Cancer Inst. 2002 Jan 16;94(2):94-101
references: 11792747
references: J Clin Oncol. 2000 Jun;18(11):2258-68
references: 10829046
references: P R Health Sci J. 1999 Jun;18(2):95-8
references: 10461314
references: Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6279-84
references: 19329485
references: BMC Med Genomics. 2008 Apr 28;1:13
references: 18442402
references: J Natl Cancer Inst. 2003 Feb 19;95(4):308-15
references: 12591987
references: Cancer Control. 2002 Jan-Feb;9(1):9-15
references: 11907461
references: Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2006-11
references: 15598755
references: J Clin Oncol. 2001 Aug 15;19(16):3622-34
references: 11504744
references: Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1019-26
references: 9539555
references: P R Health Sci J. 2007 Dec;26(4):343-8
references: 18246962
references: N Engl J Med. 2006 Jul 6;355(1):51-65
references: 16822996
references: J Invest Dermatol. 1994 Nov;103(5 Suppl):96S-101S
references: 7963692
references: Bol Asoc Med P R. 1998 Jan-Mar;90(1-3):8-11
references: 9734150